The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction
about
α1-Syntrophin Variant Identified in Drug-Induced Long QT Syndrome Increases Late Sodium CurrentA common SCN5A variant is associated with PR interval and atrial fibrillation among African AmericansA study of the SCN5A gene in a cohort of 76 patients with Brugada syndrome.A CACNA1C variant associated with reduced voltage-dependent inactivation, increased CaV1.2 channel window current, and arrhythmogenesis.Epidemiology and genetics of sudden cardiac deathA novel NaV1.5 voltage sensor mutation associated with severe atrial and ventricular arrhythmias.Gene-environment interaction between SCN5A-1103Y and hypokalemia influences QT interval prolongation in African Americans: the Jackson Heart Study.Race, common genetic variation, and therapeutic response disparities in heart failure.Impact of sex and ethnicity on arrhythmic risk.Characterization of 2 genetic variants of Na(v) 1.5-arginine 689 found in patients with cardiac arrhythmias.Common genetic variants in selected Ca²⁺ signaling genes and the risk of appropriate ICD interventions in patients with heart failure.The efficacy of Ranolazine on E1784K is altered by temperature and calcium.RyR2 Common Gene Variant G1886S and the Risk of Ventricular Arrhythmias in ICD Patients with Heart Failure.An African loss-of-function CACNA1C variant p.T1787M associated with a risk of ventricular fibrillation
P2860
Q28551060-67EC51EE-94D4-4E8A-97C2-DDA776E20C3CQ30370146-98B2877E-2AE7-4CA9-9480-715E81B0B99EQ33161757-9D9A29AC-CBF1-4833-815E-CD1F65227579Q34129061-BC57D17F-A9D8-4064-B56E-FD5BB2B86E27Q36102464-517A6A81-9184-4DEF-8C8B-0D8D489FCD01Q36680153-0EA8875B-1F0C-4999-B6B8-24B5050B8071Q37448379-5EE0667E-4E01-444B-8F71-1B26D6B3307BQ38274407-EBF4FEE0-3B36-4804-A337-6927D495A378Q38508942-EEFEC7C8-A48C-4405-BE4E-EEE75276D642Q46240331-BD21E860-31D3-4E6B-AE4D-DC8C3D7A41D5Q46332264-A31E74BF-80B1-47B0-86F6-2A71070C0FD3Q50348768-77333E24-887B-431E-A2E5-26F31EEB992AQ53291322-B02D918E-D437-4E04-B7BD-17AC97849FAFQ57050357-DCFE58A0-EF02-4521-9579-02C25B838E2C
P2860
The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The S1103Y cardiac sodium chan ...... and reduced ejection fraction
@ast
The S1103Y cardiac sodium chan ...... and reduced ejection fraction
@en
The S1103Y cardiac sodium chan ...... and reduced ejection fraction
@nl
type
label
The S1103Y cardiac sodium chan ...... and reduced ejection fraction
@ast
The S1103Y cardiac sodium chan ...... and reduced ejection fraction
@en
The S1103Y cardiac sodium chan ...... and reduced ejection fraction
@nl
prefLabel
The S1103Y cardiac sodium chan ...... and reduced ejection fraction
@ast
The S1103Y cardiac sodium chan ...... and reduced ejection fraction
@en
The S1103Y cardiac sodium chan ...... and reduced ejection fraction
@nl
P2093
P2860
P1476
The S1103Y cardiac sodium chan ...... and reduced ejection fraction
@en
P2093
Albert Y Sun
Carol Haynes
Damian Craig
Geoffrey S Pitt
Jason I Koontz
Kent R Nilsson
Patrick M Hranitzky
Simon G Gregory
Svati H Shah
P2860
P304
P356
10.1161/CIRCGENETICS.110.958652
P577
2011-04-15T00:00:00Z